Use of inhaled corticosteroids and the allergic asthma phenotype seem to be the main underlying mechanisms for reduced ACE2 expression,5,6 thus providing a plausible causal explanation for decreased risk of severe COVID-19 among asthmatics. This evidence concerns the gene ACE2 and allergic asthma.